Clinical Trial Experts Turn to AI and New Partnerships to Tackle Growing Trial Complexity
OVERVIEWClinical trial experts are increasingly deploying AI tools and forming strategic partnerships to address growing complexity in trial design, patient recruitment, site management, and data analysis. Pharmaceutical companies and contract research organizations (CROs) recognize that traditional trial management approaches cannot keep pace with increasing trial complexity and regulatory demands. AI applications in clinical trials include: (1) Patient matching and recruitment (identifying eligible patients from EHR data); (2) Site selection and management (optimizing trial site networks); (3) Protocol optimization (using historical data to improve trial design); (4) Data management (automating data collection and quality assurance); (5) Regulatory submission (preparing FDA submissions and evidence packages). The clinical trial industry is undergoing significant technological transformation driven by AI. Companies that successfully integrate AI into trial operations gain competitive advantages in speed, cost, and quality. However, regulatory uncertainty around AI-generated trial data and FDA guidance on AI in clinical trials creates challenges. Healthcare organizations and CROs should monitor FDA guidance development on AI in clinical trials and adjust their approaches accordingly. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.